Affidea invests in b-rayZ: the advisors

Affidea completed its investment in b-rayZ as part of a new financing round. In connection with the operation, Kellerhals Carrard advised b-rayZ, while Niederer Kraft Frey supported Affidea.

The context

Headquartered in Schlieren, Switzerland, medtech company b-rayZ specialises in AI-powered breast imaging solutions. Affidea Group is a European provider of community-based polyclinics, specialist services and advanced diagnostics.

Pursuant to the transaction, Affidea has joined b-rayZ’s series A extension financing round as a strategic investor. The partnership further recognizes b-rayZ as Affidea’s preferred AI partner for breast imaging.

The Kellerhals Carrard team

Partner Umberto Milano (VC/M&A, pictured) led the Kellerhals Carrard team on the matter, working alongside partner Kerim Tbaishat (tax),  senior associate Gaspare Loderer  (data protection), associate Vera Vallone (IP), associate Jascha Mattmann (VC/M&A) and paralegal Lisa Schmid.

The NKF team
Pictured from left to right: Samuel Hochstrasser, Philippe Weber, Janine Reudt-Demont

Corporate/M&A partner Philippe Weber led the NKF team on the operation, alogside corporate/M&A senior associate Samuel Hochstrasser and healthcare/regulatory partner Janine Reudt-Demont. Moreover, associate Pascal Hodel, junior associate Philipp Theiler (both corporate/M&A) and senior associate Sven Kälin (tax) further contributed to the team effort.

flavio.caci@lcpublishinggroup.com

SHARE